| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |